LeafCann gets licence to manufacture medical cannabis
9th May 2019
LeafCann Manufacturing, a subsidiary of LeafCann Group, has gained a licence from the Australian Office of Drug Control to manufacture medical cannabis.
The company said in a statement that this respresents a major milestone, and will lead to construction of “a world-class indoor facility based in South Australia” and to eventually provide medicine for the treatment of chronic pain. According to research by the Brightfield Group, the medical cannabis sector was worth $US 7.7 billion in 2016.
THE ODC IS STILL PROCESSING APPLICATIONS, regardless of the political situation.
reference:
https://www.aumanufacturing.com.au/leafcann-gets-licence-to-manufacture-medical-cannabis
GLTAH
DYOR
- Forums
- ASX - By Stock
- article
LeafCann gets licence to manufacture medical cannabis 9th May...
-
-
- There are more pages in this discussion • 623 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable